22 completed. 22 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 22 | Completed 22 |
| Phase 2 | 1 | Completed 1 |
Follow Prasugrel: new trials by email Literature Review of Prasugrel trials Research Report on Prasugrel
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Edoxaban Treatment Versus Vitamin K Antagonist in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention Edoxaban, Clopidogrel, Prasugrel - Atrial Fibrillation | Phase 3 | Completed | Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company | 1506 | 2017-02-24 | 2020-05-06 |
| Vasoactive and Anti-inflammatory Effects of Prasugrel in Acute Coronary Syndrome Prasugrel, Clopidogrel - Acute Coronary Syndrome, Unstable Angina | Phase 3 | Completed | University of Cologne | 49 | 2014-10-01 | 2015-06-11 |
| PRAsugrel or clopIdogrel In Acute Coronary SyndromE With CYP2C19 GENEtic Variants Prasugrel, Clopidogrel - Acute Coronary Syndromes | Phase 3 | Completed | Dong-A University | 70 | 2013-10-01 | 2019-02-11 |
| A Study Exploring Two Strategies of Rivaroxaban (JNJ39039039; BAY-59-7939) and One of Oral Vitamin K Antagonist in Patients With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention rivaroxaban 2.5 mg, rivaroxaban 15 mg, rivaroxaban 10 mg - Atrial Fibrillation, Percutaneous Coronary Intervention | Phase 3 | Completed | Janssen Scientific Affairs, LLC | 2124 | 2013-05-10 | 2017-09-19 |
| PraSugrel vs TicagrElor in ST-Elevation Myocardial Infarction paTients With Diabetes Mellitus ticagrelor, prasugrel - ST-Elevation Myocardial Infarction | Phase 3 | Completed | Gennaro Sardella | 50 | 2013-05-01 | 2017-06-28 |
| Prasugrel for Prevention of Early Saphenous Vein Graft Thrombosis Prasugrel, Placebo - Coronary Artery Bypass | Phase 3 | Completed | VA Office of Research and Development | 84 | 2013-02-01 | 2019-10-30 |
| Reloading Prasugrel or Clopidogrel on High Platelet Reactivity Before Percutaneous Coronary Intervention Prasugrel, Clopidogrel - Acute Coronary Syndrome | Phase 3 | Completed | Dong-A University | 76 | 2012-09-01 | 2014-12-23 |
| High Clopidogrel Dose Versus Prasugrel and Ticagrelor in High Reactive Stable Patients Clopidogrel, Prasugrel, Ticagrelor - Coronary Artery Disease | Phase 3 | Completed | University of Roma La Sapienza | 81 | 2012-07-01 | 2013-12-11 |
| Therapy With High Clopidogrel Dose or Prasugrel Standard Dose Reduces the Platelet Reactivity in Patients With Genotype Variation RESET GENE Trial Clopidogrel, prasugrel - Acute Coronary Syndrome | Phase 3 | Completed | Gennaro Sardella | 30 | 2011-10-01 | 2012-03-27 |
| Pharmacogenetic Approach to Anti-platelet Therapy for the Treatment of ST-segment Elevation Myocardial Infarction (STEMI) Point-of-Care Genetic Testing, Prasugrel - STEMI | Phase 2 / Phase 3 | Completed | Ottawa Heart Institute Research Corporation | 102 | 2011-09-01 | 2013-04-25 |
| Impact of Clopidogrel Dose Adjustment According to Platelet Reactivity Monitoring in Patients With High on Treatment Platelet Reactivity Undergoing Percutaneous Coronary Intervention PRASUGREL, Clopidogrel - Acute Coronary Syndromes | Phase 3 | Completed | Assistance Publique Hopitaux De Marseille | 187 | 2011-07-01 | 2012-05-23 |
| Early Thienopyridine Treatment to Improve Primary PCI in Patients With Acute MI Prasugrel, Clopidogrel - Myocardial Infarction, STEMI | Phase 3 | Completed | Stiftung Institut fuer Herzinfarktforschung | 63 | 2011-05-01 | 2016-06-17 |
| Ticagrelor Versus Prasugrel in Acute Coronary Syndromes After Percutaneous Coronary Intervention Prasugrel, Ticagrelor - Coronary Artery Disease, Acute Coronary Syndrome | Phase 3 | Completed | University of Patras | 44 | 2011-05-01 | 2012-06-22 |
| Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Reactivity in Patients With ST-elevation Myocardial Infarction (STEMI) Prasugrel, Clopidogrel - Myocardial Infarction | Phase 3 | Completed | University of Patras | 35 | 2011-04-01 | 2011-09-30 |
| Prasugrel Versus High Dose Clopidogrel in Patients With Stable Coronary Artery Disease and High Platelet Reactivity While on Chronic Clopidogrel Treatment Prasugrel, Clopidogrel - Coronary Artery Disease (CAD) | Phase 3 | Completed | University of Patras | 25 | 2011-02-01 | 2011-08-23 |
| Prasugrel Versus High Dose Clopidogrel in Clopidogrel Resistant Patients Undergoing Chronic Hemodialysis Prasugrel, Clopidogrel - Hemodialysis, Chronic Renal Failure | Phase 3 | Completed | University of Patras | 70 | 2010-05-01 | 2010-11-16 |
| Prasugrel Versus High Dose Clopidogrel in Clopidogrel Resistant Patients Post Percutaneous Coronary Intervention (PCI). prasugrel, clopidogrel - Coronary Artery Disease (CAD), Acute Coronary Syndrome (ACS) | Phase 3 | Completed | University of Patras | 70 | 2010-04-01 | 2010-08-24 |
| Facilitation Through Aggrastat By drOpping or Shortening Infusion Line in Patients With ST-segment Elevation Myocardial Infarction Compared to or on Top of PRasugrel Loading dOse Prasugrel, Tirofiban - ST Segment Elevation Myocardial Infarction | Phase 3 | Completed | Università degli Studi di Ferrara | 100 | 2010-04-01 | 2012-10-10 |
| A Comparison of Prasugrel at PCI or Time of Diagnosis of Non-ST Elevation Myocardial Infarction Placebo, Prasugrel - Acute Coronary Syndromes | Phase 3 | Completed | Eli Lilly and Company | 4033 | 2009-12-01 | 2014-02-28 |
| A Comparison of Antiplatelet Therapies in Asian Subjects With Acute Coronary Syndrome Prasugrel, Clopidogrel - Acute Coronary Syndrome | Phase 3 | Completed | Eli Lilly and Company | 720 | 2009-02-01 | 2011-11-02 |
Showing 20 of 22. Sign in to see all of them.
Acute Coronary Syndrome (11) · Coronary Artery Disease (5) · ST Elevation Myocardial Infarction (4) · Atrial Fibrillation (2) · Myocardial Infarction (2) · Angina, Stable (1) · Angina, Unstable (1) · Arrhythmias, Cardiac (1) · Diabetes Mellitus (1) · Heart Diseases (1) · Insulin Resistance (1) · Kidney Failure, Chronic (1) · Non-ST Elevated Myocardial Infarction (1) · Thrombosis (1)
University of Patras (5) · Eli Lilly and Company (4) · Dong-A University (2) · Gennaro Sardella (2) · Assistance Publique Hopitaux De Marseille (1) · Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company (1) · Janssen Scientific Affairs, LLC (1) · Ottawa Heart Institute Research Corporation (1) · Stiftung Institut fuer Herzinfarktforschung (1) · University of Cologne (1) · University of Roma La Sapienza (1) · Università degli Studi di Ferrara (1) · VA Office of Research and Development (1)
Italy (7) · France (6) · Germany (6) · Greece (6) · South Korea (6) · Belgium (4) · Canada (4) · Netherlands (4) · Poland (4) · Romania (4) · Taiwan (4) · United States (4) · Austria (3) · Czechia (3) · Hungary (3)
Moo Hyun Kim, MD (2) · Andreas Gotte, Prof., MD (1) · Derek Y F So, MD (1) · Jason D Roberts, MD (1) · Pascal Vranckx, MD (1) · Shuaib M. Abdullah, MD (1) · Tanja Rudolph, MD (1) · Uwe Zeymer, MD (1)
PMID 35224730, PMID 17982182, PMID 18377975, PMID 18498956, PMID 18757948, PMID 19106084, PMID 19249633, PMID 19699846, PMID 20026770, PMID 20598967, PMID 20723851, PMID 21473962, PMID 21511219, PMID 21606391, PMID 22199016, PMID 22440491, PMID 22633653, PMID 22783896, PMID 22789884, PMID 22920930, PMID 22995726, PMID 23048056, PMID 23117779, PMID 23448344, PMID 23953385, PMID 23991622, PMID 24140678, PMID 24947719, PMID 24952863, PMID 25012156, PMID 25524333, PMID 25538134, PMID 25616919, PMID 25819853, PMID 26011265, PMID 26060122, PMID 26089177, PMID 26386793, PMID 26542513, PMID 26637834, PMID 26883498, PMID 26916483, PMID 26988949, PMID 27030601, PMID 27151605, PMID 27517654, PMID 27815268, PMID 27881555, PMID 27959713, PMID 28381584
2016 (1)